Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.1500 (-0.81%) ($6.1500 - $6.1500) on Tue. Oct. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.55% (three month average) | RSI | 50 | Latest Price | $6.1500(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.1% a day on average for past five trading days. | Weekly Trend | CGEN declines -0.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(72%) ARKG(70%) ARKK(68%) IWO(66%) IBUY(65%) | Factors Impacting CGEN price | CGEN will decline at least -1.775% in a week (0% probabilities). VIXM(-52%) VXX(-37%) UUP(-12%) TLT(-8%) GLD(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.775% (StdDev 3.55%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.26 | 5 Day Moving Average | $6.25(-1.6%) | 10 Day Moving Average | $6.35(-3.15%) | 20 Day Moving Average | $6.26(-1.76%) | To recent high | -13.4% | To recent low | 5.9% | Market Cap | $509m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |